<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec><h3>Background</h3>
<p>Domperidone is a commonly prescribed galactagogue used off-label for lactation insufficiency. Prescriber unfamiliarity or safety concerns can lead to therapeutic delay and potential early breastfeeding discontinuation. To facilitate access, the study site pharmacy department developed a Structured Administration and Supply Arrangement (SASA) for International Board-Certified Lactation Consultants (IBCLC) to screen and initiate domperidone using a checklist.</p>
</sec>
<sec><h3>Material</h3>
<p>To validate a domperidone screening tool via analysis of its use and compliance, together with a staff satisfaction survey.</p>
</sec>
<sec><h3>Methods</h3>
<p>Records were extracted from the REDCap® database for women with documented domperidone supply between 06/05/2022 and 27/01/2023 and reviewed with medical records. A staff survey was distributed assessing compliance and attitudes towards the SASA.</p>
</sec>
<sec><h3>Results</h3>
<p>Records of supply revealed that 34% (17/50) of patients were referred to a physician, revealing a discrepancy between database documentation and checklists, as no referrals were documented. Overall staff satisfaction with the SASA was rated 4.6 out of 5. 77.7% (7/9) felt confident counselling and supplying domperidone with the SASA in place. 88.9% (8/9) felt confident using the checklist to identify the appropriateness of therapy and referral to a physician.</p>
</sec>
<sec><h3>Conclusions</h3>
<p>The system in place allows the IBCLCs to initiate and supply domperidone in a timely manner to breastfeeding mothers with lactation insufficiency. The support tools, including domperidone SASA, REDCap® documentation database and the checklist domperidone as a Galactagogue Checklist, can be greatly appreciated by the LCs. Continued discussion with IBCLCs to refine and improve the SASA and associated education package will result in more consistent compliance.</p>
</sec>
</abstract>

Background
Domperidone is a commonly prescribed galactagogue used off-label for lactation insufficiency. Prescriber unfamiliarity or safety concerns can lead to therapeutic delay and potential early breastfeeding discontinuation. To facilitate access, the study site pharmacy department developed a Structured Administration and Supply Arrangement (SASA) for International Board-Certified Lactation Consultants (IBCLC) to screen and initiate domperidone using a checklist.

Material
To validate a domperidone screening tool via analysis of its use and compliance, together with a staff satisfaction survey.

Methods
Records were extracted from the REDCap® database for women with documented domperidone supply between 06/05/2022 and 27/01/2023 and reviewed with medical records. A staff survey was distributed assessing compliance and attitudes towards the SASA.

Results
Records of supply revealed that 34% (17/50) of patients were referred to a physician, revealing a discrepancy between database documentation and checklists, as no referrals were documented. Overall staff satisfaction with the SASA was rated 4.6 out of 5. 77.7% (7/9) felt confident counselling and supplying domperidone with the SASA in place. 88.9% (8/9) felt confident using the checklist to identify the appropriateness of therapy and referral to a physician.

Conclusions
The system in place allows the IBCLCs to initiate and supply domperidone in a timely manner to breastfeeding mothers with lactation insufficiency. The support tools, including domperidone SASA, REDCap® documentation database and the checklist domperidone as a Galactagogue Checklist, can be greatly appreciated by the LCs. Continued discussion with IBCLCs to refine and improve the SASA and associated education package will result in more consistent compliance.

Analysis of a Pharmacy Developed, Outpatient Lactation Consultant Initiated Domperidone Programme

Journal of Mother and Child

This work is licensed under the Creative Commons Attribution 4.0 International License.

Background
Domperidone is a commonly prescribed galactagogue used off-label for lactation insufficiency. Prescriber unfamiliarity or safety concerns can lead...

Analysis of a Pharmacy Developed, Outpatient Lactation Consultant Initiated Domperidone Programme

Article Category: Research Article

Pubblicato online: 19 apr 2024

Pagine: 23 - 32

Ricevuto: 09 ott 2023

Accettato: 23 feb 2024

DOI: https://doi.org/10.34763/jmotherandchild.20242801.d-23-00093

Parole chiave
Lactation, Breastmilk, Breastfeeding, Domperidone, Lactation Consultant, Pharmacy, International Board-Certified Lactation Consultants (IBCLC)

© 2024 Katherine Chinnery et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Analysis of a Pharmacy Developed, Outpatient Lactation Consultant Initiated Domperidone Programme

Article Category: Research Article

Pubblicato online: 19 apr 2024

Pagine: 23 - 32

Ricevuto: 09 ott 2023

Accettato: 23 feb 2024

DOI: https://doi.org/10.34763/jmotherandchild.20242801.d-23-00093

Parole chiaveLactation, Breastmilk, Breastfeeding, Domperidone, Lactation Consultant, Pharmacy, International Board-Certified Lactation Consultants (IBCLC)

© 2024 Katherine Chinnery et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Parole chiave
Lactation, Breastmilk, Breastfeeding, Domperidone, Lactation Consultant, Pharmacy, International Board-Certified Lactation Consultants (IBCLC)